查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1498737

放射治疗市场，按放射性同位素、方法、应用和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Radiotheranostics Market, By Radioisotope, By Approach, By Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年放射治疗市场规模为 21.152 亿美元，2024 年至 2032 年复合年增长率为 14.20%。

放射治疗市场-市场动态

癌症盛行率不断上升推动市场成长

预计随着癌症发生率的上升，放射治疗市场将继续发展。不受控制地生长的身体细胞扩散到身体的其他部位称为癌症。当涉及癌症时，用于诊断和治疗目的的放射性核素探针被用来以有针对性和选择性的方式检测和治疗特定的（通常是癌性的）细胞。每个探头都是根据患者的基本状况量身定制的，可改善治疗结果和效率。这就是放射性核医超越个人化医疗的方式。例如，根据英国癌症研究组织英国癌症研究中心的数据，2020 年发现了超过 1,800 万例新癌症病例。此外，预计到 2040 年，全球癌症病例将增加 2,800 万例，较 2020 年增加 54.9%，与女性（增加 48.8%）相比，这种增加对男性（增加 60.6%）的影响不成比例。因此，放射治疗市场受到癌症发生率上升的推动。

放射治疗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 14.20% 左右的复合年增长率成长

根据方法细分，预计目标治疗类别将在 2023 年显示最大的市场份额

从应用细分来看，肿瘤学类别是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

放射治疗市场細項分析：

全球放射治疗市场根据放射性同位素、方法、应用和区域进行细分。

市场依放射性同位素分为两类：碘131、碘123、镓68、镓177、18F和Y-90等放射性同位素。镥 177 类别在市场上占据主导地位，这得益于市场上不断增长的 LU-177 产品使用和可用性。此外，Lu-177 的半衰期比其他治疗同位素更长，因此可以实现更长的疗程，并可能获得更好的患者治疗效果。例如，Springer 指出 L-177 的物理半衰期为 6.7 天。最近的产品批准和新产品的发布也加速了该领域的成长。此外，诺华于 2022 年 12 月获得欧盟委员会批准上市 Pluvicto，这是一种靶向放射性配体疗法，用于治疗前列腺癌。

市场依应用分为以下几类：肿瘤学（甲状腺癌、神经内分泌肿瘤、肝细胞癌、摄护腺癌、其他肿瘤学应用）及非肿瘤学（神经系统疾病、关节炎、其他非肿瘤学应用）。肿瘤学类别在市场中占据主导地位，并可能在预测期内保持其主导地位。这一高比例可以用癌症放射治疗产品在太空中广泛使用这一事实来解释。此外，新产品的批准、即将推出的产品以及开发尖端成像工具和治疗解决方案的不断变化的需求都预计将推动行业扩张。 Pluvicto、LUTATHERA、AZEDRA 和其他癌症相关治疗诊断就是几个例子。由于医疗保健专业人员对核医学的偏好，癌症放射治疗药物的有效性有所提高。此外，预计癌症疾病创新核医学研究支出的增加将支持业务成长。

放射治疗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

在预测期内，预计北美将占据全球放射治疗市场的最大份额。对治疗性放射性药物的需求、精准医疗的成长趋势以及高效成像技术的使用增加正在推动北美放射治疗市场的发展。此外，该地区的产业正受到众多产业参与者及其不同策略努力的推动。例如，2023 年 3 月，Ratio Therapeutics Inc. 宣布已获得默克公司用于 PET 影像的标靶药物的许可。

此外，预计亚太地区的放射治疗市场将以全球最快的速度扩张。该地区癌症发病率高和核子医学投资不断增长是推动该地区市场成长的主要因素。例如，2021 年 3 月，Global Medical Solutions, Ltd. 和 BWXT Medical Ltd. 宣布，他们将合作在亚太地区生产和提供放射性药物和放射性同位素。亚太地区核子造影方法的增加也促进了市场的采用。

放射治疗市场-竞争格局：

Telix Pharmaceuticals Limited.、Novartis AG、IsoTherapeutics Group, LLC、Bayer AG 和 Progenics Pharmaceuticals, Inc.( Lantheus) 等放射治疗领域的知名企业正在实施多项战略措施，以巩固其地位并保持其地位竞争力。为了改善放射治疗技术，他们大力资助研发 (R&D) 项目，这些项目专注于创造新型放射性药物、增强显像剂和扩大治疗潜力。为了获取资源、交流知识和利用专业知识，他们正在与学术机构、研究中心和其他产业参与者结盟。此外，行业领导者之间的合作伙伴关係使企业能够提高产品品质、扩大客户群并加快新产品的开发。

最近的发展：

2023 年 3 月：Pharma 15 Corporation 是一家总部位于美国的公司，专注于开发用于前列腺癌的尖端治疗放射性药物，已被 Radiopharm Theranostics 收购。透过这项精心策划的倡议，Radiopharm Theranostics 能够获得前列腺癌治疗方面的尖端技术和知识，从而扩大其产品组合併巩固其在放射治疗行业的地位。

2023 年 6 月：Thor Medical 是一家年轻的製造商，生产用于治疗癌症的放射性药物的 α 发射体，被 Nordic Nanovector 收购。透过整合 Thor Medical 的知识和 α 发射器技术，这项经过深思熟虑的倡议增强了 Nordic Nanovector 的能力，使其产品线多样化，并巩固了其在癌症市场的地位。

目录

第一章：放射治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 放射治疗市场片段（按放射性同位素）
    • 按方法分類的放射治疗市场摘要
    • 按应用分類的放射治疗市场片段
    • 按国家/地区分類的放射治疗市场摘要
    • 按地区分類的放射治疗市场摘要
  • 竞争洞察

第 3 章：放射治疗主要市场趋势

  • 放射治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 放射治疗市场限制
    • 市场限制影响分析
  • 放射治疗市场机会
  • 放射治疗市场未来趋势

第 4 章：放射治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：放射治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：放射治疗市场格局

  • 2023 年放射治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：放射治疗市场 - 按放射性同位素

  • 概述
    • 按放射性同位素分類的细分市占率分析
    • 碘131
    • 洛丁-123
    • 镓68
    • 镥177
    • 18F 配备 Y-90
    • 其他放射性同位素

第 8 章：放射治疗市场 - 依方法

  • 概述
    • 按方法分類的细分市场占有率分析
    • 标靶治疗
    • 针对性诊断

第 9 章：放射治疗市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 肿瘤学
      • 甲状腺癌
      • 神经内分泌肿瘤
      • 肝细胞癌
      • 摄护腺癌
      • 其他肿瘤学应用
    • 非肿瘤学
      • 神经系统疾病
      • 关节炎
      • 其他非肿瘤学应用

第 10 章：放射治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美放射治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美洲市场规模与预测（按放射性同位素）
    • 北美市场规模和预测（按方法）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲放射治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲放射性同位素市场规模与预测
    • 欧洲市场规模与预测（按方法）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区放射治疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区放射性同位素市场规模与预测
    • 亚太地区市场规模与预测（依方法）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲放射治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按放射性同位素）
    • 拉丁美洲市场规模与预测（按方法）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲放射治疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按放射性同位素）
    • 中东和非洲市场规模及预测（依方法）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 放射治疗产业

  • 竞争仪表板
  • 公司简介
    • Telix Pharmaceuticals Limited.
    • Novartis AG
    • IsoTherapeutics Group, LLC
    • Bayer AG
    • Progenics Pharmaceuticals, Inc.( Lantheus)
    • ITM Radiopharma
    • Q BioMed Inc.
    • Life Molecular Imaging
    • RadioMedix
    • Nordic Nanovector ASA
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2906

REPORT HIGHLIGHT

Radiotheranostics Market size was valued at USD 2,115.2 Million in 2023, expanding at a CAGR of 14.20% from 2024 to 2032.

Radiotheranostics is a new area of medicine that combines the use of radiopharmaceuticals for both therapeutic and diagnostic purposes. It includes the simultaneous diagnosis and treatment of illnesses with the use of radiotracers, which are molecules tagged with radioactive isotopes. It involves using single-photon emission computed tomography (SPECT) or positron emission tomography (PET) imaging to see particular molecular targets or biomarkers within the body. Giving comprehensive details regarding the location and severity of the disease facilitates accurate and customized diagnosis. The therapeutic component entails applying the same radiotracer or a comparable substance to give targeted radiation therapy directly to the site of sickness.

Radiotheranostics Market- Market Dynamics

Growing Cancer Prevalence to Propel Market Growth

It is anticipated that the market for radiotheranostics will continue to develop as cancer incidence rises. Uncontrollably growing body cells that spread to other parts of the body are known as cancerous conditions. When it comes to cancer, radionuclide probes that are paired for both diagnostic and therapeutic purposes are used to detect and treat specific (usually cancerous) cells in a targeted and selective manner. Each probe is tailored to the patient's underlying condition, improving treatment outcomes and efficiency. This is how radionuclide medicine goes beyond personalized medicine. For instance, over 18 million new instances of cancer were discovered in 2020, according to Cancer Research UK, a UK-based cancer research organization. Furthermore, it is projected that by 2040, there will be 28 million additional instances of cancer worldwide, a 54.9% rise from 2020 and that this increase would disproportionately affect men (60.6% increase) compared to women (48.8% increase). Consequently, the market for radiotheranostics is driven by the rising incidence of cancer.

Radiotheranostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.20% over the forecast period (2024-2032)

Based on approach segmentation, the targeted therapeutic category was predicted to show maximum market share in the year 2023

Based on application segmentation, the oncology category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Radiotheranostics Market- Segmentation Analysis:

The Global Radiotheranostics Market is segmented on the basis of Radioisotope, Approach, Application, and Region.

The market is divided into two categories based on radioisotope: Iodine-131, lodine-123, Gallium-68, Lutetium-177, 18F with Y-90, and Other radioisotopes. The lutetium-177 category dominates the market, which is fueled by the market's growing LU-177 product usage and availability. Furthermore, Lu-177 has a longer half-life than other therapeutic isotopes, allowing for a longer course of treatment and possibly better patient outcomes. For instance, Springer states that L-177 has a 6.7-day physical half-life. Recent product approvals and fresh releases have also accelerated the segment's growth. Moreover, Novartis was granted European Commission approval in December 2022 to market Pluvicto, a targeted radioligand therapy, for the treatment of prostate cancer.

The market is divided into the following categories based on application: Oncology (Thyroid cancer, Neuroendocrine tumors, Hepatocellular carcinoma, Prostate cancer, Other oncology applications) and Non-oncology (Neurological disorders, Arthritis, Other non-oncology applications). The oncology category dominates the market and is likely to maintain its dominance during the forecast period. This high percentage can be explained by the fact that cancer radiotheranostics items are widely available in space. Furthermore, new product approvals, impending product launches, and the changing need for developing cutting-edge imaging tools and treatment solutions are all projected to fuel industry expansion. Pluvicto, LUTATHERA, AZEDRA, and other cancer-related theranostics are a few examples. The effectiveness of cancer radiotheranostic drugs has increased due to healthcare professionals' preference for nuclear medicine. Furthermore, it is anticipated that rising research expenditures in innovative nuclear medicine for cancer disorders will support business growth.

Radiotheranostics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for radiotheranostics. The market for radiotheranostics in North America is being pushed by the demand for therapeutic radiopharmaceuticals, a growing trend towards precision medicine, and the increased usage of efficient imaging technologies. Moreover, the sector in the area is being driven by a multiplicity of industrial actors and their different strategic endeavours. For example, in March 2023, Ratio Therapeutics Inc. announced that it has licenced a Merck targeted medication used in PET imaging.

In addition, the radiotheranostics market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific. The high cancer prevalence in the area and growing nuclear medicine investments are the main factors propelling the growth of the regional market. For instance, in March 2021, Global Medical Solutions, Ltd. and BWXT Medical Ltd. announced that they will be working together to produce and provide radiopharmaceuticals and radioisotopes across the Asia Pacific region. An increase in nuclear imaging methods in Asia Pacific is also contributing to the market adoption.

Radiotheranostics Market- Competitive Landscape:

Several strategic measures are being implemented by prominent players such as Telix Pharmaceuticals Limited., Novartis AG, IsoTherapeutics Group, LLC, Bayer AG, and Progenics Pharmaceuticals, Inc.( Lantheus), among others in the radiotheranostics sector to fortify their position and maintain their competitiveness. To improve radiotheranostics technologies, they are heavily funding research and development (R&D) projects that concentrate on creating novel radiopharmaceuticals, enhancing imaging agents, and expanding therapeutic potential. To gain access to resources, exchange knowledge, and capitalize on expertise, they are forming alliances with academic institutions, research centers, and other industry participants. Furthermore, partnerships among industry leaders enable businesses to improve the caliber of their products, broaden their customer base, and expedite the creation of new products.

Recent Developments:

March 2023: Pharma 15 Corporation, a US-based business focused on creating cutting-edge therapeutic radiopharmaceuticals for prostate cancer, has been acquired by Radiopharm Theranostics. Through this calculated move, Radiopharm Theranostics was able to expand its portfolio and solidify its position in the radiotheranostics industry by gaining access to cutting-edge technology and knowledge in the treatment of prostate cancer.

June 2023: Thor Medical, a young manufacturer of alpha-emitters for radiopharmaceuticals intended to cure cancer, was acquired by Nordic Nanovector. By incorporating Thor Medical's knowledge and alpha-emitter technology, this calculated move strengthened Nordic Nanovector's capabilities, diversifying its product line and solidifying its position in the cancer market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RADIOTHERANOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Telix Pharmaceuticals Limited.

Novartis AG

IsoTherapeutics Group, LLC

Bayer AG

Progenics Pharmaceuticals, Inc.( Lantheus)

ITM Radiopharma

Q BioMed Inc.

Life Molecular Imaging

RadioMedix

Nordic Nanovector ASA

Others

GLOBAL RADIOTHERANOSTICS MARKET, BY RADIOISOTOPE- MARKET ANALYSIS, 2019 - 2032

  • Iodine-131
  • lodine-123
  • Gallium-68
  • Lutetium-177
  • 18F with Y-90
  • Other radioisotopes

GLOBAL RADIOTHERANOSTICS MARKET, BY APPROACH- MARKET ANALYSIS, 2019 - 2032

  • Targeted therapeutic
  • Targeted diagnostic

GLOBAL RADIOTHERANOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Thyroid cancer
  • Neuroendocrine tumors
  • Hepatocellular carcinoma
  • Prostate cancer
  • Other oncology applications
  • Non-oncology
  • Neurological disorders
  • Arthritis
  • Other non-oncology applications

GLOBAL RADIOTHERANOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Radiotheranostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Radiotheranostics Market Snippet by Radioisotope
    • 2.1.2. Radiotheranostics Market Snippet by Approach
    • 2.1.3. Radiotheranostics Market Snippet by Application
    • 2.1.4. Radiotheranostics Market Snippet by Country
    • 2.1.5. Radiotheranostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Radiotheranostics Key Market Trends

  • 3.1. Radiotheranostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Radiotheranostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Radiotheranostics Market Opportunities
  • 3.4. Radiotheranostics Market Future Trends

4. Radiotheranostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Radiotheranostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Radiotheranostics Market Landscape

  • 6.1. Radiotheranostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Radiotheranostics Market - By Radioisotope

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Radioisotope, 2023 & 2032 (%)
    • 7.1.2. Iodine-131
    • 7.1.3. lodine-123
    • 7.1.4. Gallium-68
    • 7.1.5. Lutetium-177
    • 7.1.6. 18F with Y-90
    • 7.1.7. Other radioisotopes

8. Radiotheranostics Market - By Approach

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Approach, 2023 & 2032 (%)
    • 8.1.2. Targeted therapeutic
    • 8.1.3. Targeted diagnostic

9. Radiotheranostics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Oncology
      • 9.1.2.1. Thyroid cancer
      • 9.1.2.2. Neuroendocrine tumors
      • 9.1.2.3. Hepatocellular carcinoma
      • 9.1.2.4. Prostate cancer
      • 9.1.2.5. Other oncology applications
    • 9.1.3. Non-oncology
      • 9.1.3.1. Neurological disorders
      • 9.1.3.2. Arthritis
      • 9.1.3.3. Other non-oncology applications

10. Radiotheranostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Radiotheranostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Radiotheranostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Radiotheranostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Radiotheranostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Radiotheranostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Radiotheranostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Telix Pharmaceuticals Limited.
    • 11.2.2. Novartis AG
    • 11.2.3. IsoTherapeutics Group, LLC
    • 11.2.4. Bayer AG
    • 11.2.5. Progenics Pharmaceuticals, Inc.( Lantheus)
    • 11.2.6. ITM Radiopharma
    • 11.2.7. Q BioMed Inc.
    • 11.2.8. Life Molecular Imaging
    • 11.2.9. RadioMedix
    • 11.2.10. Nordic Nanovector ASA
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Radiotheranostics Market: Radioisotope Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Radioisotope
  • TABLE Global Radiotheranostics Market, by Radioisotope 2019-2032 (USD Million)
  • TABLE Radiotheranostics Market: Approach Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Approach
  • TABLE Global Radiotheranostics Market, by Approach 2019-2032 (USD Million)
  • TABLE Radiotheranostics Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Radiotheranostics Market, by Application 2019-2032 (USD Million)
  • TABLE Radiotheranostics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Radiotheranostics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE North America Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE North America Radiotheranostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Europe Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE Europe Radiotheranostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Asia Pacific Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE Asia Pacific Radiotheranostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Latin America Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE Latin America Radiotheranostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Radiotheranostics Market, by Application, 2019-2032 (USD Million)